Career Opportunities

The NINDS Clinical Trials Unit (CTU) has opportunities for both postbaccalaureate Intramural Research Training Awardees (IRTA) and post-doctoral fellows.

CTU postbaccalaureate IRTA

The CTU Intramural Research Training Award (IRTA) provides post-baccalaureates graduates who are interested in clinical research, the opportunity to work with a dynamic group of clinical research staff engaged in supporting research teams within the NIH Division of Intramural Research program of the National Institute of Neurological Disorders and Stroke (NINDS).  Members of the CTU provide clinical research support in a variety of areas, e.g., biostatistics, regulatory support, clinical trials oversight, data management, and staffing support.  The CTU IRTA will have an opportunity to work with members of the CTU, on a research project focused on optimizing methods and practices in clinical research and clinical trials.

The Postbac IRTA Program is for individuals who meet ONE of the following criteria:

  1. College graduates who received their bachelor's degrees less than THREE years prior to the date they begin the program (regardless of whether they subsequently completed a master's degree), OR
  2. Individuals who are more than 3 years past the receipt of their bachelor's degree but received a master's degree less than SIX MONTHS before they begin the program OR
  3. Individuals who meet criterion (1) and/or (2) who have been accepted into graduate, other doctoral, or medical school programs and who have written permission from their school to delay entrance for up to one year to pursue a biomedical research project at the NIH.
Eligibility Requirements for IRTA Program
To be eligible, candidates must also be U.S. citizens or permanent residents. In addition, they should intend to apply to graduate or professional school during their tenure at the NIH (if they have not already been accepted).

NINDS-FDA/Neurology-Clinical Trial Methodology and Regulatory Science Fellowship

The NINDS Clinical Trials Unit, together with the Division of Neurology (DN) 1, 2, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), offers a NINDS-FDA/Neurology-Clinical Trial Methodology and Regulatory Science Fellowship.  The Fellow receives training in all aspects of clinical trials including concept evaluation, protocol development, statistical design, trial implementation, safety monitoring, ethical considerations, and regulatory sciences. During the first year, the emphasis is on acquiring the basic skills necessary for the conduct of clinical research with most activities taking place at NIH along with early exposure to the FDA environment. During the second year, increasing independence in clinical research is accompanied by more intensive participation in the full spectrum of activities in DN, ranging from pre-investigational discussions with clinical investigators about first-in-human drug trials to analysis of complicated multi-center trials leading to possible approval of new medical products. In addition, Fellows engage in implementing a clinical research project at the NIH Clinical Center and participate in a weekly subspecialty clinic of their choice. The program is customized but generally includes coursework on clinical research methodology and statistics. This fellowship is suitable for neurologists or neurosurgeons with a strong interest in clinical research methodology.   

Eligibility Requirements for FDA Fellowship
Eligibility Requirements:  We seek applicants planning careers in clinical neurology or neurosurgery and therapeutics development in academic medicine, government service, or other settings. Graduates of accredited residency programs or clinical fellows in neurology or neurosurgery in academia or at the NIH are encouraged to apply. Priority will be given to applicants who have identified an area of clinical interest in a given subspecialty or disease area and who have developed plans or pilot studies for potential clinical research projects. Applications are accepted during the course of the year and are accepted on a rolling admission. Selected candidates will be invited for an interview. Fellowships are available on an annual basis.

For Fellowship inquiries, please email:

Current and Prior CTU Intramural Research Training Awardees (IRTA)

Katherine Landry, CTU IRTA
Katherine Landry
2023 - Present

Research aim:  Optimizing classification of adverse events in clinical research of neurological disease

Manahel Zahid, CTU IRTA
Manahel Zahid
2022 - Present

Research aim:  Retrospective Assessment of Equitable Inclusion of Subjects in the National Institute of Neurological Disorders and Stroke Clinical Studies

Matthew Gooden
Matthew Gooden, MS
2019 - 12/2021
Current Position: Protocol Monitoring Specialist, NIH/NINDS Clinical Trials Unit

Research aims: Risk-based monitoring of clinical research; Effects of training on the incidence of protocol related non-compliance events; Reducing clinical research non-compliance due to the COVID-19 pandemic

Samantha McGrath
Samantha McGrath, BS
1/2015 – 12/2015
Current Position: Clinical Trial Manager, Amgen

Technical IRTA:  Developed expertise in the auditing of clinical trials in the intramural research program

Austin Amos, MD
Austin Amos, MD
10/2013 – 8/2014
Current Position: Resident, Trident Medical Center

Technical IRTA:  Developed expertise in the auditing of clinical trials in the intramural research program

Trena Mukherjee, DrPH, MPH
Trena Mukherjee, DrPH, MPH
9/2011 – 8/2013
Current Position: Epidemiologist, USAID

Technical IRTA:  Developed expertise in the auditing of clinical trials in the intramural research program


Past and Present NINDS-FDA/Neurology-Clinical Trial Methodology and Regulatory Science Fellowship

Jonathan Pomeraniec, MD, MBA
Jonathan Pomeraniec, MD, MBA
2019 – 2021
Current Position: Neurosurgery Resident, NIH/NINDS

Research aims:

  • Corticotrophin-releasing hormone (CRH) stimulation for 18F-FDG-PET detection of pituitary adenoma in Cushing’s disease.
  • The effect of Vorinostat on ACTH-producing pituitary adenomas in Cushing’s disease.
  • Helping Enable Real-time Observations; A Brain Tumor Surveillance Study (HERO): Feasibility study of wearable technology, machine learning and deep molecular phenotyping for early detection of symptom transitions in high grade brain tumors.


Brian Trummer, MD
Brian Trummer, MD, Ph.D.
2017 – 2019
Current Position: Clinical Reviewer, CDER FDA

Research aim:

  • Clinical Trial Designs and Measures in Hereditary Spastic Paraplegias
Dietrich Haubenberger, MD
Dietrich Haubenberger, MD
2015 – 2017
Current Position: Executive Medical Director, Neurocrine Biosciences

Research aims:

  • Essential Tremor
  • Tremor Analysis via Novel Technology